Effective-component compatibility of Bufei Yishen formula III ameliorated COPD by improving airway epithelial cell senescence by promoting mitophagy via the NRF2/PINK1 pathway. This evidence concerns the gene NFE2L2 and chronic obstructive pulmonary disease.